BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11007998)

  • 1. Tumor-promoting functions of adenosine.
    Spychala J
    Pharmacol Ther; 2000; 87(2-3):161-73. PubMed ID: 11007998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growth.
    Allard B; Turcotte M; Stagg J
    J Biomed Biotechnol; 2012; 2012():485156. PubMed ID: 23125525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth, angiogenesis, neovascularization, macrophage infiltration and metastasis.
    Koszałka P; Gołuńska M; Stanisławowski M; Urban A; Stasiłojć G; Majewski M; Wierzbicki P; Składanowski AC; Bigda J
    Int J Biochem Cell Biol; 2015 Dec; 69():1-10. PubMed ID: 26545615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenascin C interacts with ecto-5'-nucleotidase (eN) and regulates adenosine generation in cancer cells.
    Sadej R; Inai K; Rajfur Z; Ostapkowicz A; Kohler J; Skladanowski AC; Mitchell BS; Spychala J
    Biochim Biophys Acta; 2008 Jan; 1782(1):35-40. PubMed ID: 18062933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific Activation of A3, A2A and A1 Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration.
    Koszałka P; Gołuńska M; Urban A; Stasiłojć G; Stanisławowski M; Majewski M; Składanowski AC; Bigda J
    PLoS One; 2016; 11(3):e0151420. PubMed ID: 26964090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of ecto-5'nucleotidase from porcine endothelial cells after exposure to human blood: Implications for xenotransplantation.
    Khalpey Z; Yuen AH; Kalsi KK; Kochan Z; Karbowska J; Slominska EM; Forni M; Macherini M; Bacci ML; Batten P; Lavitrano M; Yacoub MH; Smolenski RT
    Biochim Biophys Acta; 2005 Jun; 1741(1-2):191-8. PubMed ID: 15955461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting A2 adenosine receptors in cancer.
    Allard D; Turcotte M; Stagg J
    Immunol Cell Biol; 2017 Apr; 95(4):333-339. PubMed ID: 28174424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine Adenosine Regulates Tumor Polyfunctional CD73
    Gourdin N; Bossennec M; Rodriguez C; Vigano S; Machon C; Jandus C; Bauché D; Faget J; Durand I; Chopin N; Tredan O; Marie JC; Dubois B; Guitton J; Romero P; Caux C; Ménétrier-Caux C
    Cancer Res; 2018 Jul; 78(13):3604-3618. PubMed ID: 29559470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular adenosine produced by ecto-5'-nucleotidase (CD73) regulates macrophage pro-inflammatory responses, nitric oxide production, and favors Salmonella persistence.
    Costales MG; Alam MS; Cavanaugh C; Williams KM
    Nitric Oxide; 2018 Jan; 72():7-15. PubMed ID: 29108754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).
    Hoskin DW; Mader JS; Furlong SJ; Conrad DM; Blay J
    Int J Oncol; 2008 Mar; 32(3):527-35. PubMed ID: 18292929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression.
    Bono MR; Fernández D; Flores-Santibáñez F; Rosemblatt M; Sauma D
    FEBS Lett; 2015 Nov; 589(22):3454-60. PubMed ID: 26226423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adenosine signaling in the pathogenesis of breast cancer.
    Bahreyni A; Samani SS; Rahmani F; Behnam-Rassouli R; Khazaei M; Ryzhikov M; Parizadeh MR; Avan A; Hassanian SM
    J Cell Physiol; 2018 Mar; 233(3):1836-1843. PubMed ID: 28383816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive activities of adenosine in cancer.
    Allard B; Beavis PA; Darcy PK; Stagg J
    Curr Opin Pharmacol; 2016 Aug; 29():7-16. PubMed ID: 27209048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine pathway and cancer: where do we go from here?
    Antonioli L; Haskó G; Fornai M; Colucci R; Blandizzi C
    Expert Opin Ther Targets; 2014 Sep; 18(9):973-7. PubMed ID: 24958495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies on the role of Th17 in cancer: a TGF-β-dependent immunosuppressive activity?
    Martin F; Apetoh L; Ghiringhelli F
    Trends Mol Med; 2012 Dec; 18(12):742-9. PubMed ID: 23083809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine stimulates 5'-nucleotidase activity in rat mesangial cells via A2 receptors.
    Stefanovic V; Vlahovic P; Savic V; Ardaillou N; Ardaillou R
    FEBS Lett; 1993 Sep; 331(1-2):96-100. PubMed ID: 8405420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecto-5'-nucleotidase-positive cells in the choroid and ciliary body of the rat eye.
    Braun JS
    Anat Rec (Hoboken); 2010 Mar; 293(3):379-82. PubMed ID: 20091887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5'-ectonucleotidase mediates multiple-drug resistance in glioblastoma multiforme cells.
    Quezada C; Garrido W; Oyarzún C; Fernández K; Segura R; Melo R; Casanello P; Sobrevia L; San Martín R
    J Cell Physiol; 2013 Mar; 228(3):602-8. PubMed ID: 22833450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine signaling: Next checkpoint for gastric cancer immunotherapy?
    Shi L; Yang L; Wu Z; Xu W; Song J; Guan W
    Int Immunopharmacol; 2018 Oct; 63():58-65. PubMed ID: 30075429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cancer cells suppress effector functions of cytotoxic T cells through the adenosinergic pathway.
    Mora-García ML; Ávila-Ibarra LR; García-Rocha R; Weiss-Steider B; Hernández-Montes J; Don-López CA; Gutiérrez-Serrano V; Titla-Vilchis IJ; Fuentes-Castañeda MC; Monroy-Mora A; Jave-Suárez LF; Chacón-Salinas R; Vallejo-Castillo L; Pérez-Tapia SM; Monroy-García A
    Cell Immunol; 2017 Oct; 320():46-55. PubMed ID: 28950987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.